Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne Mouries-Martin

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|August 31, 2019
ReplyAlexis Mathian, Suzanne Mouries-Martin, Karim Dorgham, et al.
Annals of the Rheumatic Diseases|October 2, 2019
Ultrasensitive serum interferon-α quantification during SLE remission identifies patients at risk for relapseAlexis Mathian, Suzanne Mouries-Martin, Karim Dorgham, et al.
Journal of Translational Medicine|December 4, 2020
The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcomeMathieu Blot, Jean-Baptiste Bour, Jean Pierre Quenot, et al.
Journal of Translational Medicine|March 9, 2021
Correction to: The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcomeMathieu Blot, Jean-Baptiste Bour, Jean Pierre Quenot, et al.
European Cytokine Network|June 13, 2025
Serum interferon-beta level determined by an ultrasensitive electrochemiluminescence immunoassay is increased in clinically active and inactive systemic lupus erythematosusKarim Dorgham, Omaira Da Mata Jardin, Clara Mellot, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 4, 2018
Monitoring Disease Activity in Systemic Lupus Erythematosus With Single-Molecule Array Digital Enzyme-Linked Immunosorbent Assay Quantification of Serum Interferon-αAlexis Mathian, Suzanne Mouries-Martin, Karim Dorgham, et al.
Annals of the Rheumatic Diseases|August 16, 2022
Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-αAlexis Mathian, Paul Breillat, Karim Dorgham, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Arthritis & Rheumatology (Hoboken, N.J.)|August 31, 2019
ReplyAlexis Mathian, Suzanne Mouries-Martin, Karim Dorgham, et al.
Annals of the Rheumatic Diseases|October 2, 2019
Ultrasensitive serum interferon-α quantification during SLE remission identifies patients at risk for relapseAlexis Mathian, Suzanne Mouries-Martin, Karim Dorgham, et al.
Journal of Translational Medicine|December 4, 2020
The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcomeMathieu Blot, Jean-Baptiste Bour, Jean Pierre Quenot, et al.
Journal of Translational Medicine|March 9, 2021
Correction to: The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcomeMathieu Blot, Jean-Baptiste Bour, Jean Pierre Quenot, et al.
European Cytokine Network|June 13, 2025
Serum interferon-beta level determined by an ultrasensitive electrochemiluminescence immunoassay is increased in clinically active and inactive systemic lupus erythematosusKarim Dorgham, Omaira Da Mata Jardin, Clara Mellot, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 4, 2018
Monitoring Disease Activity in Systemic Lupus Erythematosus With Single-Molecule Array Digital Enzyme-Linked Immunosorbent Assay Quantification of Serum Interferon-αAlexis Mathian, Suzanne Mouries-Martin, Karim Dorgham, et al.
Annals of the Rheumatic Diseases|August 16, 2022
Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-αAlexis Mathian, Paul Breillat, Karim Dorgham, et al.
Pageof 1